Chipotle Mexican Grill Inc. (NYSE: CMG) reported fiscal first-quarter results on Thursday which showed profit jumping 22% thanks to higher customers traffic, offsetting rising food price inflation.
Continue reading Chipotle Comfortably Beats Q1 Earnings Expectations, Maintains Outlook (CMG)
Shares of Theravance Inc. (NASDAQ: THRX) rallied about 15% by afternoon trade after a federal advisory panel on Wednesday said that proposed lung treatment drug, Breo Ellipta, jointly developed by GlaxoSmithKline PLC and Theravance was not only effective but also safe and confirmed that it will approve the product . Breo Ellipta, which is meant to treat chronic obstructive pulmonary disease or COPD, is once-a-day inhalation drug.
Continue reading Major Movers on April 18; THRX, CLB, SNDK, EBAY, MS
U.S. equity market kicked off 2013 on a strong note, with all three benchmark indexes posting significant gains in the first quarter. The rally was driven mainly by an improving outlook for the U.S. economy. The big question is can the rally continue in the second quarter?
Although PepsiCo Inc. (NYSE: PEP) reported that its fiscal first-quarter earnings declined 4.6% due to restructuring costs and increased spending on advertising and charge linked to devaluation of Venezuelan currency, shares of the beverage Company climbed on Thursday as adjusted earnings and revenue edged past Street’s estimate.
Continue reading PepsiCo Posts Strong Q1 Earnings, Maintains Outlook (PEP)
Shares of Harbor Island Development Corp. (OTC: HIDC), a Chesterfield, Virginia-based company that has brought together leaders in multichannel marketing for launching new products and services to the market, are soaring in trading today. At last check, HIDC shares were trading 32.89% higher at $0.0505 on above average volume of 20.11 million.
Shares of Alkermes Plc (NASDAQ: ALKS) skyrocketed 16% in regular trading hours on Wednesday after the biopharmaceutical company said that its stage-2 clinical trial on the unbranded drug called ALKS 5461 showed that it was effective in treating patients suffering from major depressive disorder (MDD). In a statement, the Company said that study conducted among 142 patients showed that the treatment ALKS 5461, which is a one-a day, non-addictive oral medicine, “significantly reduced” depressive symptoms among patients.
Continue reading Shares of Alkermes Soar on MDD Treatment Potential (ALKS)
Alkermes Plc (NASDAQ: ALKS) rallied after the company said its mid-stage clinical trial of the drug ALKS 5451, meant to cure depressive disorders, showed it was capable of “significantly reducing” symptoms of depression. The Company said that it carried studies on 142 patients. Based on the outcome of clinical trials, the Company now intends to hold a meeting with the U.S Food and Drug Administration (FDA) and commence later stage studies.
Continue reading Major Movers on April 17; ALKS, CSX, BAC, MAT, AAPL, CAT
Shares of Cereplast Inc. (PINK: CERP), a company engaged in the development and commercialization of bio-based resins, are soaring in trading today. At last check, CERP shares were trading 58.14% higher at $0.0340 on above average volume of 48.41 million. The stock touched an intra-day high of $0.04 earlier today. CERP shares have gained more than 69% in the last three trading sessions.
Mattel Inc. (NASDAQ: MAT) reported a strong growth in fiscal first quarter earnings on Monday as toy maker’s top line was boosted by robust sales of Monster High and American Girl Dolls while fatter margin also helped driving up the bottom line.
Continue reading Mattel Q1 Results Edge Past Street’s Estimates, Shares Gain (MAT)
Although the world’s largest chip maker Intel Corp. (NASDAQ: INTC) reported slightly lower-than-expected fiscal first-quarter earnings and revenue on Tuesday, investors’ faith in the Company remained intact as guidance on the second quarter matched with Wall Street expectations.